Author

Kazutaka Kikuta

Observed names: K. Kikuta, Kazutaka KIKUTA, Kikuta, Kazutaka

Observed institutions: Tohoku University, Keio University, National Cancer Centre Japan, Keio University Hospital, Tochigi Cancer Center, Tachikawa Hospital, National Cancer Center Hospital, Center for Northeast Asian Studies, Tohoku University, National Cancer Center Research Institute, National Institute of Advanced Industrial Science and Technology, The University of Tokyo, The University of Osaka

ORCID: 0000-0001-8054-9738

Observed ORCID: 0000-0001-8054-9738

OpenAlex ID: A5003705308

Analysis of microRNAs expressions in chondrosarcoma

2013 · Teruhito Yoshitaka, Akira Kawai, et al. · Journal of Orthopaedic Research® · 76

PDF

An Analysis of Factors Related to Recurrence of Myxofibrosarcoma

2013 · K. Kikuta, D. Kubota, et al. · Japanese Journal of Clinical Oncology · 63

Nucleophosmin as a Candidate Prognostic Biomarker of Ewing's Sarcoma Revealed by Proteomics

2009 · Kazutaka Kikuta, Naobumi Tochigi, et al. · Clinical Cancer Research · 60

Clinical proteomics identified ATP-dependent RNA helicase DDX39 as a novel biomarker to predict poor prognosis of patients with gastrointestinal stromal tumor

2011 · Kazutaka Kikuta, Daisuke Kubota, et al. · Journal of Proteomics · 56

An analysis of factors related to the tail-like pattern of myxofibrosarcoma seen on MRI

2014 · Kazutaka Kikuta, Daisuke Kubota, et al. · Skeletal Radiology · 52

Postoperative deep infection in tumor endoprosthesis reconstruction around the knee

2010 · Takeshi Morii, Hiroo Yabe, et al. · Journal of Orthopaedic Science · 49

Results of sub-analysis of a phase 2 study on trabectedin treatment for extraskeletal myxoid chondrosarcoma and mesenchymal chondrosarcoma

2016 · Hideo Morioka, Shunji Takahashi, et al. · BMC Cancer · 46

PDF

Global Protein-expression Analysis of Bone and Soft Tissue Sarcomas

2008 · Akira Kawai, Tadashi Kondo, et al. · Clinical Orthopaedics and Related Research · 43

PDF

Peroxiredoxin 2 as a chemotherapy responsiveness biomarker candidate in osteosarcoma revealed by proteomics

2010 · Kazutaka Kikuta, Naobumi Tochigi, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 41

Compact Folded-Fin Tapered Slot Antenna for UWB Applications

2015 · Kazutaka Kikuta, Akira Hirose · IEEE Antennas and Wireless Propagation Letters · 37

CT guided cryoablation for locally recurrent or metastatic bone and soft tissue tumor: initial experience

2016 · Michiro Susa, Kazutaka Kikuta, et al. · BMC Cancer · 36

PDF

Preoperative Denosumab Therapy Against Giant Cell Tumor of Bone is Associated with an Increased Risk of Local Recurrence After Curettage Surgery

2022 · Naofumi Asano, Masato Saito, et al. · Annals of Surgical Oncology · 34

Pfetin as a Prognostic Biomarker in Gastrointestinal Stromal Tumor: Novel Monoclonal Antibody and External Validation Study in Multiple Clinical Facilities

2009 · K. Kikuta, M. Gotoh, et al. · Japanese Journal of Clinical Oncology · 34

Secernin-1 as a novel prognostic biomarker candidate of synovial sarcoma revealed by proteomics

2011 · Yoshiyuki Suehara, Naobumi Tochigi, et al. · Journal of Proteomics · 31

An Active Metamaterial Antenna With MEMS-Modulated Scanning Radiation Beams

2016 · Yong Luo, Kazutaka Kikuta, et al. · IEEE Electron Device Letters · 30

Mesenchymal chondrosarcoma: A Japanese Musculoskeletal Oncology Group (JMOG) study on 57 patients

2017 · Yusuke Tsuda, Koichi Ogura, et al. · Journal of Surgical Oncology · 26

PDF

Validation Study on Pfetin and ATP-dependent RNA Helicase DDX39 as Prognostic Biomarkers in Gastrointestinal Stromal Tumour

2012 · D. Kubota, T. Okubo, et al. · Japanese Journal of Clinical Oncology · 25

Novel MR imaging method – MAVRIC – for metal artifact suppression after joint replacement in musculoskeletal tumor patients

2015 · Michiro Susa, Sota Oguro, et al. · BMC Musculoskeletal Disorders · 23

PDF

Proteomic approach toward personalized sarcoma treatment: Lessons from prognostic biomarker discovery in gastrointestinal stromal tumor

2012 · Tadashi Kondo, Yoshiyuki Suehara, et al. · PROTEOMICS - CLINICAL APPLICATIONS · 22

A histological positive margin after surgery is correlated with high local re-recurrence rate in patients with recurrent myxofibrosarcoma

2016 · Kazutaka Kikuta, Robert Nakayama, et al. · Japanese Journal of Clinical Oncology · 21

Successful Treatment with Pazopanib for Multiple Lung Metastases of Inguinal Epithelioid Sarcoma: A Case Report

2015 · Sanae Irimura, Kazumasa Nishimoto, et al. · Case Reports in Oncology · 20

PDF

Discoidin, CUB and LCCL domain-containing protein 2 (DCBLD2) is a novel biomarker of myxofibrosarcoma invasion identified by global protein expression profiling

2017 · Kazutaka Kikuta, Daisuke Kubota, et al. · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · 19

Discovery of Biomarkers for Osteosarcoma by Proteomics Approaches

2012 · Yoshiyuki Suehara, Daisuke Kubota, et al. · Sarcoma · 16

PDF

Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing

2023 · Nobuhiko Hasegawa, Takuo Hayashi, et al. · Clinical Orthopaedics and Related Research · 14

Establishment and characterization of the NCC-GCTB4-C1 cell line: a novel patient-derived cell line from giant cell tumor of bone

2021 · Takuya Ono, Rei Noguchi, et al. · Human Cell · 14

Works count: 72

Citation count: 1,117

H-index: 20

I10-index: 35